Stay updated on ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Sign up to get notified when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T18:22:35.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.9%
    Check dated 2025-02-10T09:17:19.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T04:56:14.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T19:25:27.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.2%
    Check dated 2025-01-12T16:10:55.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T12:17:21.000Z thumbnail image

Stay in the know with updates to ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASG-22CE Dose Escalation in Nectin-4+ Tumors Clinical Trial page.